Grant: Dissemination Events - PA: Musculoskeletal Hlth, Arthritis, Skin & Oral Health
University of Alberta
$25,000.00
Canadian Recommendations for SLE management
FY 2012-13
Summary
Systemic lupus erythematosus (SLE) is an autoimmune disease with the potential to affect many organs through various immune mechanisms including autoantibodies. Disease diagnosis and management have been historically difficult due to the heterogeneity of disease presentations, damage from chronic disease, limited treatment options and increased morbidity and mortality from both the disease and treatments. Recently, the approval of belimumab by Health Canada and introduction of several potential SLE treatments through various phases of clinical trials in Canada have increased the potential treatment options for SLE patients. However, the management of these patients is complicated by multiple factors including: (1) variable access to an SLE-specialist (ie. Rheumatologist, general internist), (2) provincial differences in coverage of medications in SLE, and (3) a lack of a gold standard-of-care in the evaluation and management of SLE patients. The Canadian Rheumatology Association (CRA) recently endorsed recommendations in the pharmacotherapy of rheumatoid arthritis (RA) to create a Canadian standard-of-care in RA management given the significant increase in therapeutics in this area. With new biologics now emerging for SLE, recommendations in managing SLE are needed and confirmed in a recent needs assessment of the CRA membership. In this application, we seek funds to host two Canadian meetings of SLE stakeholders including rheumatologists, patients, primary care and other subspecialists. The first meeting will discuss the results of a comprehensive needs assessment for SLE management to identify the most important aspects of SLE care needing review and then reconvene at a second meeting to vote on recommendations for SLE management for dissemination to the CRA membership and all interested stakeholders.
Department
Program
Dissemination Events - PA: Musculoskeletal Hlth, Arthritis, Skin & Oral Health
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
264675
Name
Keeling Stephanie
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Dissemination Events Grants
Projecttitle
Canadian Recommendations for SLE management
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Alberta
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Dissemination Events - PA: Musculoskeletal Hlth, Arthritis, Skin & Oral Health
Keyworddelim
Management; Recommendations; Systemic Lupus Erythematosus (Sle); Treatment
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease with the potential to affect many organs through various immune mechanisms including autoantibodies. Disease diagnosis and management have been historically difficult due to the heterogeneity of disease presentations, damage from chronic disease, limited treatment options and increased morbidity and mortality from both the disease and treatments. Recently, the approval of belimumab by Health Canada and introduction of several potential SLE treatments through various phases of clinical trials in Canada have increased the potential treatment options for SLE patients. However, the management of these patients is complicated by multiple factors including: (1) variable access to an SLE-specialist (ie. Rheumatologist, general internist), (2) provincial differences in coverage of medications in SLE, and (3) a lack of a gold standard-of-care in the evaluation and management of SLE patients. The Canadian Rheumatology Association (CRA) recently endorsed recommendations in the pharmacotherapy of rheumatoid arthritis (RA) to create a Canadian standard-of-care in RA management given the significant increase in therapeutics in this area. With new biologics now emerging for SLE, recommendations in managing SLE are needed and confirmed in a recent needs assessment of the CRA membership. In this application, we seek funds to host two Canadian meetings of SLE stakeholders including rheumatologists, patients, primary care and other subspecialists. The first meeting will discuss the results of a comprehensive needs assessment for SLE management to identify the most important aspects of SLE care needing review and then reconvene at a second meeting to vote on recommendations for SLE management for dissemination to the CRA membership and all interested stakeholders.
Competitiondate
201206
Approvedterm2
1 yr 0 mth
Pinamesdelim
Keeling, Stephanie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $25,000~ $0~